ACTIVE

Mercken Management

Export PDF

Financial year 2025 · Closed on 30/06/2025

Net result2 M €+186 536,2 %over 1 year
Gross margin10,6 k €-92,7 %over 1 year
Equity3 M €+136,9 %over 1 year
Workforce0,0 ETP

Identity

Source · BCE/KBO

Mercken Management is a Private limited company incorporated in 2005. Its main activity is: Management consultancy activities. Its registered office is in Hasselt.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0874.831.023
Incorporation
04/07/2005
Legal form
Private limited company
Registered office
Luikersteenweg 154
3500 Hasselt · FlandreSee on map
Contributed capital
12 500,00 €
Latest accounts
30/06/2025
Average workforce
0,0 ETP
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 20 filings

Trend over 11 financial years

20252024202320222013
Income statement
Gross margin10,6 k €144,8 k €324,5 k €390,5 k €113,3 k €
EBITDA6,6 k €105,9 k €287,3 k €357,7 k €109,1 k €
Operating result-117 k €3,3 k €247,2 k €341,2 k €99,5 k €
Net result2 M €1,1 k €432,5 k €324,6 k €58,3 k €
Balance sheet
Equity3 M €1,3 M €1,3 M €1,5 M €139,9 k €
Total assets4,1 M €2,4 M €3,1 M €2,3 M €345,8 k €
Cash327,6 k €87,6 k €241,4 k €370,1 k €43,4 k €
Debts796,9 k €1,1 M €1,4 M €818,8 k €205,9 k €
Other
Workforce0,0 ETP––––

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation

Board of directors

Source · NBB, accounts to 30/06/2025

1 active · 4 ended

Active mandates

Koen Mercken

Director

Active

Ended mandates

Koen Mercken

Bestuurder · since 24 juin 2005

Ended
Koen Mercken

Director · since 24 juin 2005

Ended
Koen Mercken

Manager · since 24 juin 2005

Ended
Koen Mercken

Manager

Ended

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelMicro modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/07/202401/07/202301/07/202201/07/202101/07/202001/07/2019
Closing of the financial year30/06/202530/06/202430/06/202330/06/202230/06/202130/06/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date27/01/202604/02/202529/01/202430/01/202325/01/202216/12/2020
General meeting15/11/202516/11/202418/11/202319/11/202220/11/202121/11/2020
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model30/06/202515/11/202527/01/2026DutchPDF
Micro model30/06/202416/11/202404/02/2025DutchPDF
Micro model30/06/202318/11/202329/01/2024DutchPDF
Micro model30/06/202219/11/202230/01/2023DutchPDF
Micro model30/06/202120/11/202125/01/2022DutchPDF
Micro model30/06/202021/11/202016/12/2020DutchPDF
Micro model30/06/201916/11/201917/12/2019DutchPDF
Micro model30/06/201817/11/201814/01/2019DutchPDF
Micro model30/06/201718/11/201723/11/2017DutchPDF
Abridged model30/06/201619/11/201609/12/2016DutchPDF
Abridged model30/06/201521/11/201515/12/2015DutchPDF
Abridged model30/06/201415/11/201408/12/2014DutchPDF
Abridged model30/06/201316/11/201309/01/2014DutchPDF
Abridged model30/06/201217/11/201214/12/2012DutchPDF
Abridged model30/06/201119/11/201130/11/2011DutchPDF
Abridged model30/06/201020/11/201010/12/2010DutchPDF
Abridged model30/06/200921/11/200921/01/2010DutchPDF
Abridged model30/06/200815/11/200811/12/2008DutchPDF
Abridged model30/06/200717/11/200708/02/2008DutchPDF
Abridged model30/06/200618/11/200609/02/2007DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 30/06/2025

1 active · 4 ended

Active mandates

Koen Mercken

Director

Active

Ended mandates

Koen Mercken

Bestuurder · since 24 juin 2005

Ended
Koen Mercken

Director · since 24 juin 2005

Ended
Koen Mercken

Manager · since 24 juin 2005

Ended
Koen Mercken

Manager

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Registered office28/02/2025
    MAATSCHAPPELIJKE ZETEL
    PDF
  • Mandates24/11/2023
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - BENAMING - DIVERSEN - ONTSLAGEN - BENOEMINGEN - KAPITAAL - AANDELEN
    PDF
  • Mandates16/10/2019
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other12/07/2005
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 20252 M €↑
  2. 2024
    Annual accounts 20241,1 k €↓
  3. 2023
    Annual accounts 2023432,5 k €↑
  4. 2022
    Annual accounts 2022324,6 k €↑
  5. 2013
    Annual accounts 201358,3 k €↑
  6. 2012
    Annual accounts 201230 k €↓
  7. 2011
    Annual accounts 201137,3 k €↑
  8. 2010
    Annual accounts 20107 k €↓
  9. 2009
    Annual accounts 200990 k €↑
  10. 2008
    Annual accounts 200849,8 k €↓
  11. 2007
    Annual accounts 200773,1 k €
  12. 04/07/2005
    IncorporationPrivate limited company